For millions of people living with depression, finding an effective treatment can feel like a long and uncertain journey.

An AI-powered biomarker based on histology alone predicted survival among men with metastatic hormone-sensitive prostate cancer and identified those who benefitted from escalation to triplet therapy.

A collaborative research team has identified a novel blood-based biomarker capable of detecting early-stage lung cancer and ...

Expanding on IVBM insights, Robert Kratzke, MD, discusses biomarkers, NGS panels, and treatment options for early-stage NSCLC without actionable alterations.

Spear Bio, an innovator in ultrasensitive protein biomarker detection, today announced plans to unveil new SPEAR immunoassay ...

PrimeC is now FDA-cleared to enter Phase III development in ALS, as competition in the indication intensifies with several ...

Learn why comprehensive biomarker testing is essential before starting any lung cancer treatment. Hear from patients and ...

Full-body MRIs, multi-omics blood tests, continuous glucose monitors, wearable health trackers and advanced biomarker panels ...

The rarity of sarcoma complicates clinical trial design and biomarker-driven treatment, explains Alexander Spira, MD, PhD, ...

A new wearable biomarker, 'Entropy,' measuring body energy consumption, has stirred the bio-hacking community. While the name ...

Longevity medicine relies on advanced biomarker analysis to support preventive healthcare and more personalized patient ...